Blue Trust’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$46.2K Sell
1,058
-373
-26% -$17.3K ﹤0.01% 1254
2026
Q2
$61.1K Sell
1,431
-713
-33% -$38.7K ﹤0.01% 1265
2026
Q1
$135K Sell
2,144
-269
-11% -$21.5K ﹤0.01% 901
2025
Q4
$230K Sell
2,413
-233
-9% -$22.8K ﹤0.01% 724
2025
Q3
$258K Buy
2,646
+623
+31% +$64.5K ﹤0.01% 712
2025
Q2
$217K Sell
2,023
-2,977
-60% -$301K ﹤0.01% 740
2025
Q1
$504K Buy
5,000
+575
+13% +$57.9K 0.01% 406
2024
Q4
$395K Sell
4,425
-6,067
-58% -$534K 0.01% 445
2024
Q3
$808K Buy
10,492
+5,017
+92% +$395K 0.01% 319
2024
Q2
$375K Buy
5,475
+2,437
+80% +$178K 0.01% 485
2024
Q1
$208K Buy
3,038
+1,553
+105% +$100K ﹤0.01% 483
2023
Q4
$79K Buy
1,485
+142
+11% +$7.58K ﹤0.01% 777
2023
Q3
$73K Buy
1,343
+78
+6% +$4.09K ﹤0.01% 718
2023
Q2
$63K Sell
1,265
-911
-42% -$47.6K ﹤0.01% 624
2023
Q1
$100K Buy
2,176
+43
+2% +$2.03K ﹤0.01% 765
2022
Q4
$83K Sell
2,133
-92
-4% -$3.98K ﹤0.01% 727
2022
Q3
$83K Sell
2,225
-400
-15% -$16K ﹤0.01% 595
2022
Q2
$116K Buy
+2,625
New +$107K ﹤0.01% 455

Other funds holding BSX

Blue Trust's BSX Position: Q3 2026 in Review

Blue Trust reduced its Boston Scientific (BSX) stake by 26% in Q3 2026, selling an estimated $17.3K and leaving 1,058 shares worth $46.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1254.

Blue Trust first reported a position in BSX in Q2 2022 and has held it in 18 quarters since. The position peaked at $808K in Q3 2024. 1,312 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Blue Trust held 1,058 shares of Boston Scientific worth $46.2K as of Q3 2026.
  • Blue Trust sold 373 Boston Scientific shares in Q3 2026, an estimated $17.3K.
  • Boston Scientific made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #1254 holding.
  • Blue Trust first reported a position in Boston Scientific in Q2 2022 and has held it in 18 quarters since.
  • Blue Trust's Boston Scientific position peaked at $808K in Q3 2024.
  • 1,312 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.